Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

QIAGEN Shares Outstanding 2010-2024 | QGEN

QIAGEN shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • QIAGEN shares outstanding for the quarter ending June 30, 2024 were 0.222B, a 3.7% decline year-over-year.
  • QIAGEN 2023 shares outstanding were 0.231B, a 0.21% increase from 2022.
  • QIAGEN 2022 shares outstanding were 0.23B, a 2.25% increase from 2021.
  • QIAGEN 2021 shares outstanding were 0.225B, a 0.93% decline from 2020.
  
QIAGEN Annual Shares Outstanding
(Millions of Shares)
2023 231
2022 230
2021 225
2020 227
2019 220
2018 226
2017 226
2016 232
2015 231
2014 236
2013 226
2012 225
2011 223
2010 225
2009 200
QIAGEN Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 222
2024-03-31 227
2023-12-31 231
2023-09-30 221
2023-06-30 231
2023-03-31 231
2022-12-31 230
2022-09-30 221
2022-06-30 223
2022-03-31 223
2021-12-31 225
2021-09-30 225
2021-06-30 225
2021-03-31 224
2020-12-31 227
2020-09-30 229
2020-06-30 227
2020-03-31 225
2019-12-31 220
2019-09-30 220
2019-06-30 226
2019-03-31 227
2018-12-31 226
2018-09-30 228
2018-06-30 227
2018-03-31 226
2017-12-31 226
2017-09-30 226
2017-06-30 226
2017-03-31 228
2016-12-31 232
2016-09-30 232
2016-06-30 232
2016-03-31 231
2015-12-31 231
2015-09-30 221
2015-06-30 221
2015-03-31 222
2014-12-31 236
2014-09-30 226
2014-06-30 225
2014-03-31 227
2013-12-31 226
2013-09-30 226
2013-06-30 219
2013-03-31 226
2012-12-31 225
2012-09-30 226
2012-06-30 224
2012-03-31 223
2011-12-31 223
2011-09-30 223
2011-06-30 225
2011-03-31 225
2010-12-31 224
2010-09-30 223
2010-06-30 226
2010-03-31 220
2009-12-31 225
2009-09-30 195
2009-06-30 190
2009-03-31 190
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.144B $1.965B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $173.240B 17.33
Vertex Pharmaceuticals (VRTX) United States $120.784B 0.00
Regeneron Pharmaceuticals (REGN) United States $111.578B 26.34
Gilead Sciences (GILD) United States $107.244B 18.33
Bristol Myers Squibb (BMY) United States $107.046B 38.54
CSL (CSLLY) Australia $96.183B 0.00
GSK (GSK) United Kingdom $83.399B 9.67
Alnylam Pharmaceuticals (ALNY) United States $34.778B 0.00
Argenex SE (ARGX) Netherlands $31.125B 0.00
BioNTech SE (BNTX) Germany $27.930B 0.00
Biogen (BIIB) United States $27.058B 11.42
BeiGene (BGNE) Cayman Islands $23.373B 0.00
Moderna (MRNA) United States $22.626B 0.00
Illumina (ILMN) United States $22.302B 152.17
Genmab (GMAB) Denmark $15.648B 19.55
BioMarin Pharmaceutical (BMRN) United States $13.254B 39.21
Incyte (INCY) United States $12.665B 822.00
Exact Sciences (EXAS) United States $12.660B 0.00
Vaxcyte (PCVX) United States $12.486B 0.00
Insmed (INSM) United States $12.023B 0.00
Bio-Techne Corp (TECH) United States $11.781B 46.12
Sarepta Therapeutics (SRPT) United States $11.252B 256.50
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Legend Biotech (LEGN) United States $8.904B 0.00
Roivant Sciences (ROIV) United Kingdom $8.512B 0.00
Revolution Medicines (RVMD) United States $8.267B 0.00
Ascendis Pharma (ASND) Denmark $7.841B 0.00
Intra-Cellular Therapies (ITCI) United States $7.739B 0.00
Repligen (RGEN) United States $7.648B 116.71
Exelixis (EXEL) United States $7.254B 22.31
Viking Therapeutics (VKTX) United States $6.940B 0.00
Nuvalent (NUVL) United States $6.562B 0.00
Halozyme Therapeutics (HALO) United States $6.418B 16.89
Cytokinetics (CYTK) United States $6.401B 0.00
Zealand Pharma (ZLDPF) Denmark $5.924B 0.00
Blueprint Medicines (BPMC) United States $5.548B 0.00
Avidity Biosciences (RNA) United States $5.025B 0.00
Krystal Biotech (KRYS) United States $4.941B 330.73
Ultragenyx Pharmaceutical (RARE) United States $4.920B 0.00
Biohaven (BHVN) United States $4.847B 0.00
ADMA Biologics Inc (ADMA) United States $4.737B 78.17
Arcellx (ACLX) United States $4.459B 0.00
Immunovant (IMVT) United States $4.394B 0.00
Alkermes (ALKS) Ireland $4.379B 15.37
Axsome Therapeutics (AXSM) United States $3.968B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.861B 0.00
Denali Therapeutics (DNLI) United States $3.797B 0.00
Merus (MRUS) Netherlands $3.553B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.500B 0.00
Apellis Pharmaceuticals (APLS) United States $3.276B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.047B 0.00
Amicus Therapeutics (FOLD) United States $3.013B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.987B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.917B 0.00
Edgewise Therapeutics (EWTX) United States $2.844B 0.00
Iovance Biotherapeutics (IOVA) United States $2.689B 0.00
Kymera Therapeutics (KYMR) United States $2.676B 0.00
Protagonist Therapeutics (PTGX) United States $2.602B 16.86
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.579B 0.00
Guardant Health (GH) United States $2.570B 0.00
Geron (GERN) United States $2.544B 0.00
IDEAYA Biosciences (IDYA) United States $2.491B 0.00
Zai Lab (ZLAB) China $2.454B 0.00
Apogee Therapeutics (APGE) United States $2.441B 0.00
Twist Bioscience (TWST) United States $2.428B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.420B 81.06
Janux Therapeutics (JANX) United States $2.400B 0.00
Bavarian Nordic (BVNRY) Denmark $2.376B 12.84
CG Oncology (CGON) United States $2.329B 0.00
ImmunityBio (IBRX) United States $2.312B 0.00
Structure Therapeutics (GPCR) United States $2.304B 0.00
SpringWorks Therapeutics (SWTX) United States $2.302B 0.00
Neumora Therapeutics (NMRA) United States $2.290B 0.00
Scholar Rock Holding (SRRK) United States $2.223B 0.00
Myriad Genetics (MYGN) United States $2.213B 0.00
Keros Therapeutics (KROS) United States $2.175B 0.00
Vera Therapeutics (VERA) United States $2.134B 0.00
Novavax (NVAX) United States $2.030B 0.00
Vericel (VCEL) United States $2.008B 0.00
Celldex Therapeutics (CLDX) United States $1.995B 0.00
Akero Therapeutics (AKRO) United States $1.979B 0.00
Galapagos (GLPG) Belgium $1.933B 0.00
Beam Therapeutics (BEAM) United States $1.932B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.910B 17.23
Ligand Pharmaceuticals (LGND) United States $1.886B 32.06
Certara (CERT) United States $1.824B 59.68
Mirum Pharmaceuticals (MIRM) United States $1.806B 0.00
Intellia Therapeutics (NTLA) United States $1.793B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.776B 0.00
MannKind (MNKD) United States $1.768B 64.30
Arvinas (ARVN) United States $1.716B 0.00
Fortrea Holdings (FTRE) United States $1.716B 53.19
Belite Bio (BLTE) United States $1.684B 0.00
NeoGenomics (NEO) United States $1.666B 0.00
Arcus Biosciences (RCUS) United States $1.622B 0.00
NovoCure (NVCR) Jersey $1.586B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.559B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.514B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.501B 0.00
Viridian Therapeutics (VRDN) United States $1.455B 0.00
Nurix Therapeutics (NRIX) United States $1.416B 0.00
Kura Oncology (KURA) United States $1.404B 0.00
Spyre Therapeutics (SYRE) United States $1.399B 0.00
Disc Medicine (IRON) United States $1.390B 0.00
Dynavax Technologies (DVAX) United States $1.388B 96.27
Travere Therapeutics (TVTX) United States $1.345B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.321B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.298B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.233B 0.00
ANI Pharmaceuticals (ANIP) United States $1.194B 16.21
Cogent Biosciences (COGT) United States $1.182B 0.00
Gyre Therapeutics (GYRE) United States $1.180B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.168B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.146B 0.00
Tyra Biosciences (TYRA) United States $1.124B 0.00
Praxis Precision Medicines (PRAX) United States $1.119B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.059B 0.00
Bicara Therapeutics (BCAX) United States $1.051B 0.00
Mesoblast (MESO) Australia $1.049B 0.00
WAVE Life Sciences (WVE) Singapore $1.049B 0.00
Vir Biotechnology (VIR) United States $1.002B 0.00
Applied Therapeutics (APLT) United States $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.939B 0.00
Immatics (IMTX) Germany $0.937B 0.00
ArriVent BioPharma (AVBP) United States $0.909B 0.00
Zymeworks (ZYME) United States $0.904B 0.00
Cullinan Therapeutics (CGEM) United States $0.896B 0.00
Sana Biotechnology (SANA) United States $0.888B 0.00
Prothena (PRTA) Ireland $0.884B 0.00
AnaptysBio (ANAB) United States $0.862B 0.00
CARGO Therapeutics (CRGX) United States $0.862B 0.00
Liquidia Technologies (LQDA) United States $0.852B 0.00
Dianthus Therapeutics (DNTH) United States $0.825B 0.00
MiMedx (MDXG) United States $0.825B 23.42
IGM Biosciences (IGMS) United States $0.806B 0.00
Replimune (REPL) United States $0.805B 0.00
Castle Biosciences (CSTL) United States $0.794B 0.00
Immunome (IMNM) United States $0.739B 0.00
Adaptive Biotechnologies (ADPT) United States $0.737B 0.00
MBX Biosciences (MBX) United States $0.735B 0.00
Erasca (ERAS) United States $0.735B 0.00
Annexon (ANNX) United States $0.734B 0.00
AbCellera Biologics (ABCL) Canada $0.734B 0.00
Tango Therapeutics (TNGX) United States $0.726B 0.00
89BIO (ETNB) United States $0.719B 0.00
Rapport Therapeutics (RAPP) United States $0.713B 0.00
Arbutus Biopharma (ABUS) United States $0.710B 0.00
Pliant Therapeutics (PLRX) United States $0.698B 0.00
Mineralys Therapeutics (MLYS) United States $0.682B 0.00
Zenas BioPharma (ZBIO) United States $0.680B 0.00
LENZ Therapeutics (LENZ) United States $0.672B 0.00
Cytek Biosciences (CTKB) United States $0.661B 0.00
Avid Bioservices (CDMO) United States $0.661B 0.00
Oric Pharmaceuticals (ORIC) United States $0.654B 0.00
CureVac (CVAC) Germany $0.651B 0.00
Olema Pharmaceuticals (OLMA) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Neurogene (NGNE) United States $0.644B 0.00
Humacyte (HUMA) United States $0.643B 0.00
Stoke Therapeutics (STOK) United States $0.629B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.627B 0.00
Astria Therapeutics (ATXS) United States $0.620B 0.00
Oculis Holding AG (OCS) Switzerland $0.616B 0.00
Entrada Therapeutics (TRDA) United States $0.602B 5.46
Arcturus Therapeutics Holdings (ARCT) United States $0.590B 0.00
Pharming Group (PHAR) Netherlands $0.587B 0.00
Abivax SA (ABVX) France $0.586B 0.00
CorMedix Inc (CRMD) United States $0.574B 0.00
Q32 Bio (QTTB) United States $0.571B 0.00
Terns Pharmaceuticals (TERN) United States $0.554B 0.00
Allogene Therapeutics (ALLO) United States $0.552B 0.00
Nuvation Bio (NUVB) United States $0.551B 0.00
Revance Therapeutics (RVNC) United States $0.549B 0.00
Celcuity (CELC) United States $0.532B 0.00
Third Harmonic Bio (THRD) United States $0.506B 0.00
Alumis (ALMS) United States $0.495B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
PureTech Health (PRTC) United States $0.482B 0.00
Alector (ALEC) United States $0.481B 0.00
Cartesian Therapeutics (RNAC) United States $0.475B 0.00
ACELYRIN, INC (SLRN) United States $0.473B 0.00
Emergent Biosolutions (EBS) United States $0.472B 0.00
Tectonic Therapeutic (TECX) United States $0.459B 0.00
REGENXBIO (RGNX) United States $0.457B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.449B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.440B 0.00
Anavex Life Sciences (AVXL) United States $0.435B 0.00
Absci (ABSI) United States $0.433B 0.00
Prime Medicine (PRME) United States $0.427B 0.00
Contineum Therapeutics (CTNM) United States $0.417B 0.00
Aura Biosciences (AURA) United States $0.413B 0.00
Foghorn Therapeutics (FHTX) United States $0.402B 0.00
GRAIL (GRAL) United States $0.401B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 0.00
Biomea Fusion (BMEA) United States $0.395B 0.00
MaxCyte (MXCT) United States $0.386B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.379B 0.00
Anika Therapeutics (ANIK) United States $0.378B 182.36
Corvus Pharmaceuticals (CRVS) United States $0.375B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
Voyager Therapeutics (VYGR) United States $0.369B 24.14
Artiva Biotherapeutics (ARTV) United States $0.360B 0.00
C4 Therapeutics (CCCC) United States $0.351B 0.00
Nautilus Biotechnology (NAUT) United States $0.350B 0.00
Fate Therapeutics (FATE) United States $0.343B 0.00
GH Research (GHRS) Ireland $0.342B 0.00
AC Immune (ACIU) Switzerland $0.335B 0.00
ITeos Therapeutics (ITOS) United States $0.335B 0.00
Inozyme Pharma (INZY) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
PepGen (PEPG) United States $0.310B 0.00
EnGene Holdings (ENGN) Canada $0.306B 0.00
Alto Neuroscience (ANRO) United States $0.304B 0.00
Kamada (KMDA) Israel $0.300B 19.33
TScan Therapeutics (TCRX) United States $0.297B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.295B 0.00
Abeona Therapeutics (ABEO) United States $0.288B 0.00
Atea Pharmaceuticals (AVIR) United States $0.287B 0.00
Sutro Biopharma (STRO) United States $0.284B 0.00
Urogen Pharma (URGN) United States $0.279B 0.00
Nkarta (NKTX) United States $0.278B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.277B 0.00
GENFIT S.A (GNFT) France $0.277B 0.00
Opthea (OPT) Australia $0.275B 0.00
UniQure (QURE) Netherlands $0.273B 0.00
Ocugen (OCGN) United States $0.273B 0.00
Alpha Teknova (TKNO) United States $0.270B 0.00
MeiraGTx Holdings (MGTX) United States $0.269B 0.00
Zura Bio (ZURA) United States $0.267B 0.00
Solid Biosciences (SLDB) United States $0.267B 0.00
Design Therapeutics (DSGN) United States $0.265B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.261B 0.00
Rezolute (RZLT) United States $0.260B 0.00
Editas Medicine (EDIT) United States $0.257B 0.00
Instil Bio (TIL) United States $0.251B 0.00
2seventy Bio (TSVT) United States $0.251B 0.00
Poseida Therapeutics (PSTX) United States $0.249B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Amarin (AMRN) Ireland $0.238B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.231B 0.00
Gossamer Bio (GOSS) United States $0.228B 0.00
Jasper Therapeutics (JSPR) United States $0.228B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.228B 0.00
Inhibrx Biosciences (INBX) United States $0.227B 0.00
Compass Therapeutics (CMPX) United States $0.222B 0.00
Codexis (CDXS) United States $0.219B 0.00
Trevi Therapeutics (TRVI) United States $0.217B 0.00
XBiotech (XBIT) United States $0.216B 0.00
Precigen (PGEN) United States $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.214B 0.00
Fulcrum Therapeutics (FULC) United States $0.213B 0.00
Cabaletta Bio (CABA) United States $0.202B 0.00
Black Diamond Therapeutics (BDTX) United States $0.201B 0.00
Eton Pharmaceuticals (ETON) United States $0.199B 0.00
ScPharmaceuticals (SCPH) United States $0.197B 0.00
Kyverna Therapeutics (KYTX) United States $0.195B 0.00
DiaMedica Therapeutics (DMAC) United States $0.192B 0.00
Candel Therapeutics (CADL) United States $0.192B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.189B 0.00
BioStem Technologies (BSEM) $0.183B 28.67
Molecular Partners AG (MOLN) Switzerland $0.180B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
Greenwich LifeSciences (GLSI) United States $0.170B 0.00
Caribou Biosciences (CRBU) United States $0.167B 0.00
Sangamo Therapeutics (SGMO) United States $0.164B 0.00
Generation Bio (GBIO) United States $0.160B 0.00
ATyr Pharma (ATYR) United States $0.160B 0.00
Scilex Holding (SCLX) United States $0.157B 0.00
Adverum Biotechnologies (ADVM) United States $0.156B 0.00
Compugen (CGEN) Israel $0.155B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
Akoya Biosciences (AKYA) United States $0.150B 0.00
23andMe Holding (ME) United States $0.149B 0.00
Ventyx Biosciences (VTYX) United States $0.146B 0.00
Inovio Pharmaceuticals (INO) United States $0.143B 0.00
Repare Therapeutics (RPTX) Canada $0.140B 0.00
Lifecore Biomedical (LFCR) United States $0.140B 0.00
Kodiak Sciences (KOD) United States $0.138B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.138B 0.00
Tenaya Therapeutics (TNYA) United States $0.136B 0.00
Vigil Neuroscience (VIGL) United States $0.135B 0.00
Immunic (IMUX) United States $0.135B 0.00
Actuate Therapeutics (ACTU) United States $0.135B 0.00
Puma Biotechnology (PBYI) United States $0.130B 13.95
Elutia (ELUT) United States $0.130B 0.00
Sagimet Biosciences (SGMT) United States $0.128B 0.00
Seres Therapeutics (MCRB) United States $0.126B 0.00
Rani Therapeutics Holdings (RANI) United States $0.126B 0.00
PDS Biotechnology (PDSB) United States $0.125B 0.00
Seer (SEER) United States $0.122B 0.00
Verastem (VSTM) United States $0.121B 0.00
Cardiff Oncology (CRDF) United States $0.117B 0.00
Oncobiologics (OTLK) United States $0.117B 0.00
Adicet Bio (ACET) United States $0.117B 0.00
Adherex Technologies (FENC) United States $0.117B 106.50
Coherus BioSciences (CHRS) United States $0.115B 0.00
Skye Bioscience (SKYE) United States $0.113B 0.00
Nuvectis Pharma (NVCT) United States $0.113B 0.00
Cellectis S.A (CLLS) France $0.108B 0.00
Invivyd (IVVD) United States $0.108B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
I-Mab (IMAB) China $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.105B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
Genenta Science S.p.A (GNTA) Italy $0.102B 0.00
INmune Bio (INMB) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Agenus (AGEN) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.098B 0.00
Clearside Biomedical (CLSD) United States $0.098B 0.00
Benitec Biopharma (BNTC) United States $0.098B 0.00
BioAtla (BCAB) United States $0.097B 0.00
BeyondSpring (BYSI) United States $0.096B 0.00
Bluebird Bio (BLUE) United States $0.096B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Adagene (ADAG) China $0.094B 0.00
FibroBiologics (FBLG) United States $0.091B 0.00
Genelux (GNLX) United States $0.090B 0.00
CytomX Therapeutics (CTMX) United States $0.090B 8.21
X4 Pharmaceuticals (XFOR) United States $0.089B 0.00
BioHarvest Sciences (CNVCF) Canada $0.087B 0.00
InflaRx (IFRX) Germany $0.087B 0.00
Inventiva S.A (IVA) France $0.087B 0.00
HilleVax (HLVX) United States $0.086B 0.00
ALX Oncology Holdings (ALXO) United States $0.085B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Werewolf Therapeutics (HOWL) United States $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
Chimerix (CMRX) United States $0.080B 0.00
CervoMed (CRVO) United States $0.079B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
Ovid Therapeutics (OVID) United States $0.078B 0.00
Galena Biopharma (SLS) United States $0.077B 0.00
Cidara Therapeutics (CDTX) United States $0.076B 0.00
Aileron Therapeutics (ALRN) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
IO Biotech (IOBT) Denmark $0.072B 0.00
Adlai Nortye (ANL) Cayman Islands $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
DBV Technologies S.A (DBVT) France $0.068B 0.00
Spero Therapeutics (SPRO) United States $0.067B 3.02
Shattuck Labs (STTK) United States $0.067B 0.00
Rapt Therapeutics (RAPT) United States $0.065B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Boundless Bio (BOLD) United States $0.065B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.063B 0.00
Kezar Life Sciences (KZR) United States $0.063B 0.00
Entera Bio (ENTX) Israel $0.063B 0.00
Renovaro (RENB) United States $0.062B 0.00
Imunon (IMNN) United States $0.061B 0.00
Leap Therapeutics (LPTX) United States $0.060B 0.00
TELA Bio (TELA) United States $0.060B 0.00
Omega Therapeutics (OMGA) United States $0.059B 0.00
Aerovate Therapeutics (AVTE) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Allakos (ALLK) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Celularity (CELU) United States $0.054B 0.00
Syros Pharmaceuticals (SYRS) United States $0.053B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.052B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.051B 0.00
Aadi Bioscience (AADI) United States $0.049B 0.00
Intensity Therapeutics (INTS) United States $0.049B 0.00
Affimed (AFMD) Germany $0.047B 0.00
Lexaria Bioscience (LEXX) Canada $0.047B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.046B 0.00
Vor Biopharma (VOR) $0.046B 0.00
Semper Paratus Acquisition (TVGN) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Immix Biopharma (IMMX) United States $0.042B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Clene (CLNN) United States $0.040B 0.00
Atara Biotherapeutics (ATRA) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
LakeShore Biopharma (LSB) China $0.036B 0.00
Bionano Genomics (BNGO) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.035B 0.00
Passage Bio (PASG) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Ocuphire Pharma (OCUP) United States $0.033B 0.00
BRIACELL THERAP (BCTX) Canada $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
Equillium (EQ) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Lumos Pharma (LUMO) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Longeveron (LGVN) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Aligos Therapeutics (ALGS) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Gritstone Bio (GRTS) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
HCW Biologics (HCWB) United States $0.021B 0.00
Biora Therapeutics (BIOR) United States $0.020B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
Chemomab Therapeutics (CMMB) Israel $0.019B 0.00
Monopar Therapeutics (MNPR) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
Cadrenal Therapeutics (CVKD) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Apollomics (APLM) United States $0.012B 0.00
Vincerx Pharma (VINC) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Tenax Therapeutics (TENX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Carmell (CTCX) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
NuCana (NCNA) United Kingdom $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Vaccinex (VCNX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00